The Female Health Company Schedules Third Quarter Conference Call for August 12, 2008
06 August 2008 - 7:17AM
PR Newswire (US)
CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- The Female Health Company
(AMEX:FHC) today announced that it will host an investor conference
call to discuss its operating results for the third quarter of
FY2008 at 11:00 a.m. Eastern Time (EDT) on Tuesday, August 12,
2008. The Company plans to report its third quarter FY2008
operating results earlier the same day. Shareholders and other
interested parties may participate in the conference call by
dialing 800-860-2442 (international participants dial 412-858-4600)
and asking to be connected to the Female Health Company Conference
Call, a few minutes before 11:00 a.m. EDT on August 12, 2008. A
replay of the call will be available one hour after the call
through 5:00 pm on August 26, 2008 by dialing 877-344-7529
(international callers dial 412-317-0088) and entering the
conference ID 422069. About The Female Health Company The Female
Health Company (FHC), headquartered in Chicago, IL, is the maker of
the FC Female Condom (FC1 and FC2), a revolutionary option offering
women dual protection against both sexually transmitted diseases,
including HIV/AIDS, and unintended pregnancy. FHC was created as a
worldwide company in February 1996 with the purchase of Chartex
Resources Ltd., the holder of exclusive worldwide rights to FC1.
The Company holds exclusive product and technology patents for FC1
in the United States, Australia, Brazil, Canada, France, Germany,
Italy, Spain, the United Kingdom, the People's Republic of China,
South Korea and Japan. Patents are pending for FC2. FHC is the sole
manufacturer and marketer of the FC1 and FC2 female condoms in the
world. The Female Health Company and its partners currently market
the Female Condom under FC Female Condom(R), FC2 Female Condom(R),
Reality(R), Femidom(R), Femy(R), and Care(R) in the rest of the
world. "Safe Harbor" statement under the Private Securities
Litigation Reform Action of 1995: The statements in this release
which are not historical fact are forward-looking statements based
upon the Company's current plans and strategies, and reflect the
Company's current assessment of the risks and uncertainties related
to its business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and
supply constraints; and other risks detailed in the Company's press
releases, shareholder communications and Securities and Exchange
Commission filings. Actual events affecting the Company and the
impact of such events on the Company's operations may vary from
those currently anticipated. For more information about the Female
Health Company visit the Company's web site at
http://www.femalehealth.com/ and http://www.femalecondom.org/. If
you would like to be added to an e-mail alert list, please send an
e-mail to Contacts: William R. Gargiulo, Jr. 231-526-1244 Donna
Felch, CFO 312-595-9123 DATASOURCE: The Female Health Company
CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch,
CFO, +1-312-595-9123, both of The Female Health Company Web site:
http://www.femalehealth.com/
Copyright
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Focus Morningstar Health Care Index Etf (American Stock Exchange): 0 recent articles
More The Female Health Company News Articles